Results 121 to 130 of about 430,871 (256)
Cancer, Volume 132, Issue 19, 1 October 2026.Abstract Background Previous studies suggest that rates of human papillomavirus (HPV) vaccine hesitancy vary by adolescent and parent sociodemographic characteristics. This study assessed trends in the characteristics of parents who did not intend to have their child vaccinated for HPV in the United States.
Dina K. Abouelella +5 more
wiley +1 more source
Human papillomavirus vaccine administration opportunities at well visits in adolescents
BMC Public HealthBackground Despite the effectiveness of the human papillomavirus (HPV) vaccine, uptake in the United States (US) remains suboptimal, with only about half of US adolescents completing the HPV vaccine series before the recommended age of 13.
Kunal Saxena +6 more
doaj +1 more source
Cancer Reports, Volume 9, Issue 10, October 2026.ABSTRACT Background Radiation therapy (RT) is central to curative treatment for oropharyngeal squamous cell carcinoma (OPSCC) but may cause late side effects that can adversely impact quality of life (QOL). As OPSCC treatment becomes more personalised, clinically meaningful QOL endpoints and their predictors are increasingly important.
Anna Lawless +11 more
wiley +1 more source
Diagnostic Cytopathology, Volume 54, Issue 10, Page 724-730, October 2026.ABSTRACT Background Anal cancer rates are rising among women, immunocompromised individuals, and Men who have sex with Men (MSM), independent of HIV status. While high‐resolution anoscopy remains the diagnostic standard, limited access has increased interest in alternative screening.
Daisy Maharjan +5 more
wiley +1 more source
VaccinesSchool nurses are uniquely positioned to educate students about immunizations, including human papillomavirus (HPV) vaccination, but schools are often without a nurse for different reasons.
Jihye Choi +2 more
doaj +1 more source
Cross‐Neutralizing and Broadly Neutralizing Human Antibodies Against Nonenveloped Viruses
European Journal of Immunology, Volume 56, Issue 10, October 2026.In this review article, Marchand et al. compare cross ‐ and broadly ‐neutralizing human antibodies against non ‐ enveloped viruses from several major families, discussing their structural characteristics, neutralization mechanisms and relevance for the development of antiviral vaccines and therapeutics.
Sarah Marchand +2 more
wiley +1 more source
Cancer ControlObjective The introduction of the Human Papillomavirus (HPV) vaccine has led to future decline in prevalence of HPV-causing cancers; however, disparities in early HPV vaccine uptake and coverage may contribute to persistent inequalities in HPV-related ...
Atinuke Ibrahim-Ojoawo +4 more
doaj +1 more source
Health Promotion Journal of Australia, Volume 37, Issue 4, October 2026.ABSTRACT Issue Addressed This study assesses how the concept of (health) research impact has been operationalised in National Health and Medical Research Council (NHMRC) Impact Case Studies, and if and how lived experience research priorities have been considered, to ascertain implications for Australian health and medical research.
Nizam Abdu +6 more
wiley +1 more source
Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review
Health Science Reports, Volume 9, Issue 10, October 2026.ABSTRACT Background and Aims Human papillomavirus (HPV) vaccination is a critical intervention for cervical cancer prevention in Africa; however, program uptake and scale‐up remain limited due to financing constraints. This scoping review mapped existing evidence on HPV vaccine financing in Africa, identifying prevailing funding mechanisms, cost ...
Kafayat Aminu +10 more
wiley +1 more source